The Market Impact Of The New Medicaid Addiction Treatment Benefits

In the past couple weeks, we’ve written extensively about the growing opioid epidemic and its consequences on both the consumer population and the health care system (see Addiction & Hospital Utilization – The Endless Loop? and Opioid Addiction – The Crisis, The Impact & The Responses). One way the Centers for Medicare & Medicaid Services (CMS) and state Medicaid programs are trying to combat this problem is through the substance use disorder (SUD) delivery system transformation waiver.

The goal of the demonstration is to improve care for consumers with SUD by encouraging states to develop a more robust SUD delivery system . . .